A RANDOMIZED TRIAL OF THE 4 MOST ACTIVE REGIMENS FOR METASTATIC NON SMALL-CELL LUNG-CANCER

被引：372

作者：

RUCKDESCHEL, JC

FINKELSTEIN, DM

ETTINGER, DS

CREECH, RH

MASON, BA

JOSS, RA

VOGL, S

机构：

[1] DANA FARBER CANC INST,BOSTON,MA

[2] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205

[3] AMER ONCOL HOSP,PHILADELPHIA,PA 19111

[4] HOSP UNIV PENN,PHILADELPHIA,PA 19104

[5] INSELSPITAL,INST MED ONCOL,CH-3010 BERN,SWITZERLAND

[6] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 01期

关键词：

D O I：

10.1200/JCO.1986.4.1.14

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：14 / 22

页数：9

共 17 条

[1] ANALYSIS OF SURVIVAL BY TUMOR RESPONSE [J].

ANDERSON, JR ;

CAIN, KC ;

GELBER, RD .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) :710-719

[2]

BITRAN JD, 1976, CANCER TREAT REP, V60, P1225

[3]

COX DR, 1972, J R STAT SOC B, V34, P187

[4] RANDOMIZED TRIAL OF 3 COMBINATIONS OF CISPLATIN WITH VINDESINE AND OR VP-16-213 IN THE TREATMENT OF ADVANCED NON SMALL-CELL LUNG-CANCER [J].

DHINGRA, HM ;

VALDIVIESO, M ;

CARR, DT ;

CHIUTEN, DF ;

FARHA, P ;

MURPHY, WK ;

SPITZER, G ;

UMSAWASDI, T .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (02) :176-183

[5] CIS-DICHLORODIAMMINEPLATINUM (II) AND VP-16-213 COMBINATION CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER [J].

GOLDHIRSCH, A ;

JOSS, RA ;

CAVALLI, F ;

SONNTAG, RW ;

BRUNNER, KW .

MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (03) :205-208

[6] CISPLATIN AND VINDESINE COMBINATION CHEMOTHERAPY FOR ADVANCED-CARCINOMA OF THE LUNG - A RANDOMIZED TRIAL INVESTIGATING 2 DOSAGE SCHEDULES [J].

GRALLA, RJ ;

CASPER, ES ;

KELSEN, DP ;

BRAUN, DW ;

DUKEMAN, ME ;

MARTINI, N ;

YOUNG, CW ;

GOLBEY, RB .

ANNALS OF INTERNAL MEDICINE, 1981, 95 (04) :414-420

[7]

HOFFMAN PC, 1983, SEMIN ONCOL, V10, P111

[8]

LONGEVAL E, 1982, CANCER, V50, P2751, DOI 10.1002/1097-0142(19821215)50:12<2751::AID-CNCR2820501210>3.0.CO

[9]

2-3

[10]

MASON BA, 1980, P AM ASSOC CANC RES, V21, P447

← 1 2 →